Pensionfund PDN Invests $3.30 Million in Healthpeak Properties, Inc. $DOC

Pensionfund PDN acquired a new stake in Healthpeak Properties, Inc. (NYSE:DOC) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 205,473 shares of the real estate investment trust’s stock, valued at approximately $3,304,000. Healthpeak Properties comprises approximately 2.2% of Pensionfund PDN’s investment portfolio, making the stock its 11th biggest holding.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. State Street Corp grew its stake in Healthpeak Properties by 1.8% during the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock worth $947,889,000 after purchasing an additional 895,460 shares in the last quarter. JPMorgan Chase & Co. raised its position in Healthpeak Properties by 41.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after purchasing an additional 8,212,504 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in Healthpeak Properties by 2.8% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 10,520,156 shares of the real estate investment trust’s stock valued at $184,208,000 after purchasing an additional 282,155 shares in the last quarter. Cullen Capital Management LLC boosted its stake in shares of Healthpeak Properties by 6.7% in the 3rd quarter. Cullen Capital Management LLC now owns 10,232,875 shares of the real estate investment trust’s stock valued at $195,960,000 after buying an additional 641,771 shares during the period. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Healthpeak Properties by 4.1% in the 3rd quarter. Dimensional Fund Advisors LP now owns 10,228,560 shares of the real estate investment trust’s stock valued at $195,873,000 after buying an additional 400,900 shares during the period. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Up 0.6%

Shares of NYSE:DOC opened at $17.16 on Tuesday. The company has a market capitalization of $11.93 billion, a PE ratio of 171.59, a P/E/G ratio of 9.13 and a beta of 1.11. The company has a current ratio of 2.82, a quick ratio of 2.82 and a debt-to-equity ratio of 1.21. Healthpeak Properties, Inc. has a twelve month low of $15.71 and a twelve month high of $20.52. The firm has a 50 day simple moving average of $17.27 and a 200-day simple moving average of $17.54.

Healthpeak Properties (NYSE:DOC) last posted its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 EPS for the quarter, beating analysts’ consensus estimates of $0.45 by $0.02. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The firm had revenue of $719.40 million for the quarter, compared to the consensus estimate of $685.14 million. During the same period last year, the firm posted $0.46 EPS. The company’s revenue was up 3.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. On average, equities analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be paid a $0.1017 dividend. This represents a c) annualized dividend and a yield of 7.1%. The ex-dividend date is Tuesday, March 17th. Healthpeak Properties’s dividend payout ratio is currently 1,220.00%.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on DOC. Jefferies Financial Group lowered shares of Healthpeak Properties from a “buy” rating to a “hold” rating and cut their target price for the stock from $21.00 to $17.00 in a research note on Monday, December 15th. Cantor Fitzgerald set a $17.00 price target on shares of Healthpeak Properties in a research note on Monday, January 5th. Argus downgraded shares of Healthpeak Properties from a “buy” rating to a “hold” rating in a research report on Thursday, February 5th. The Goldman Sachs Group began coverage on shares of Healthpeak Properties in a research report on Friday, January 9th. They issued a “neutral” rating and a $17.00 price objective on the stock. Finally, Evercore reduced their price objective on shares of Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating on the stock in a report on Wednesday, February 4th. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $19.42.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.